Indirubin, an Active Component of Indigo Naturalis, Exhibits Inhibitory Effects on Leukemia Cells via Targeting HSP90AA1 and PI3K/Akt Pathway.
Yuanzhi YaoXiaoying LiXiaoqin YangHai MouLin Wei
Published in: Anti-cancer agents in medicinal chemistry (2024)
IND, an active component of Indigo Naturalis, could inhibit CML progression, which may be achieved via inhibiting HSP90AA1 and PI3K/Akt signaling expression levels.